The U.S. Food and Drug Administration has approved Myqorzo (aficamten) for the treatment of adults with symptomatic ...

The FDA on Friday approved aficamten (Myqorzo) for symptomatic obstructive hypertrophic cardiomyopathy (HCM), drugmaker Cytokinetics announced.

Left ventricular hypertrophy (LVH) is when the heart’s main pumping chamber, the left ventricle, becomes thicker and less able to pump blood efficiently. It usually develops because of another heart ...

Panel A shows a cross-section of a normal heart (top) and an endomyocardial biopsy sample from a normal heart (bottom; with hematoxylin and eosin staining) that shows normal histologic characteristics ...

Patients with severe left ventricular dysfunction undergoing TAVI for aortic stenosis who experience an improvement in their ventricle’s function achieve mid-term mortality similar to that seen among ...

Whether percutaneous coronary intervention, when added to optimal medical therapy, can improve outcomes in patients with severe ischemic left ventricular systolic dysfunction is unknown. New research ...

The patients were suffering from persistent ventricular premature contractions (VPCs), presenting as ventricular bigeminy — a condition in which nearly every alternate heartbeat is abnormal.

Medical researchers around the world continue to discover new ways Apple Watch can help save your life. A new study from researchers at the Mayo Clinic offers a deeper look at the Apple Watch’s ECG ...

Ventricular resection is a type of open-heart surgery to reshape and resize the heart. The surgery may help to improve survival in people with heart failure. Ventricular resection is a surgical ...